USFDA issues final guidance on voluntary recalls
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Evonik invests in start-up to improve patient recovery after open-chest surgery
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
Subscribe To Our Newsletter & Stay Updated